Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, People's Republic of China.
Department of Epidemiology, Centre for Global Cardio-Metabolic Health, Brown University, Providence, RI, USA.
Clin Interv Aging. 2020 Oct 2;15:1883-1896. doi: 10.2147/CIA.S271528. eCollection 2020.
The associations of high-density lipoprotein cholesterol (HDL-C) with mortality are still unclear. We explored the associations of HDL-C with all-cause and cause-specific mortality in an adult population.
Deaths were classified into all-cause, cardiovascular, and cancer mortality. Survival curve, multivariate Cox regression, and subgroup analyses were conducted, and hazard ratio (HR) and 95% confidence interval (CI) were performed. We fitted Cox regression models for all-cause, cardiovascular, and cancer mortality to evaluate their associations with categories of HDL-C (≤30, 31-40, 41-50, 51-60 [reference], 61-70, >70 mg/dL).
A total of 42,145 (20,415 (48.44%) males, mean age 47.12±19.40 years) subjects were enrolled. At an average follow-up of 97.52±54.03 months, all-cause, cardiovascular, and cancer mortality numbers were 5,061 (12.01), 1,081 (2.56%), and 1,061 (2.52%), respectively. When compared with the reference group (HDL-C: 51-60 mg/dL), a U-shaped association was apparent for all-cause mortality, with elevated risk in participants with the lowest (≤30 mg/dL) (HR=1.33; 95% CI=1.14- 1.56) and highest (>70 mg/dL) (HR=1.14; 95% CI=1.02-1.27) HDL-C concentration. Associations for cardiovascular and cancer mortality were non-linear. An elevated risk for cancer mortality was observed in those with the highest HDL-C concentration (HR=1.06; 95% CI-0.84-1.34) compared with the reference group, although it was not statistically significant. The effect of HDL-C on mortality was adjusted by some traditional risk factors including age, gender, race, or comorbidities.
A U-shaped association was observed between HDL-C and all-cause mortality among an adult population.
高密度脂蛋白胆固醇(HDL-C)与死亡率的关系仍不清楚。我们在成年人群中探讨了 HDL-C 与全因和特定原因死亡率的关系。
将死亡分为全因、心血管和癌症死亡。进行生存曲线、多变量 Cox 回归和亚组分析,并进行危险比(HR)和 95%置信区间(CI)。我们拟合 Cox 回归模型来评估全因、心血管和癌症死亡率与 HDL-C 类别(≤30、31-40、41-50、51-60[参考]、61-70、>70mg/dL)的相关性。
共纳入 42145 名(20415 名男性(48.44%),平均年龄 47.12±19.40 岁)受试者。在平均 97.52±54.03 个月的随访中,全因、心血管和癌症死亡率分别为 5061 例(12.01%)、1081 例(2.56%)和 1061 例(2.52%)。与参考组(HDL-C:51-60mg/dL)相比,全因死亡率呈 U 型关联,最低(≤30mg/dL)(HR=1.33;95%CI=1.14-1.56)和最高(>70mg/dL)(HR=1.14;95%CI=1.02-1.27)HDL-C 浓度的参与者风险增加。心血管和癌症死亡率的相关性是非线性的。与参考组相比,最高 HDL-C 浓度组的癌症死亡率风险升高(HR=1.06;95%CI-0.84-1.34),尽管差异无统计学意义。HDL-C 对死亡率的影响通过一些传统危险因素(包括年龄、性别、种族或合并症)进行了调整。
在成年人群中,HDL-C 与全因死亡率之间存在 U 型关联。